Opinion

Video

Long-Term Success: Educating and Supporting Patients on ALK Inhibitors

Panelists discuss how proactive patient education, lipid-lowering interventions, and monitoring tools can help patients stay on ALK inhibitor therapy to realize long-term benefits.

ALK Inhibitor Therapy Management

Main Discussion Topics

  • Patient education strategies for lorlatinib therapy adherence
  • Lipid-lowering interventions to support long-term lorlatinib treatment
  • Monitoring tools for patients on ALK inhibitors
  • Patient education methodologies specific to ALK inhibitor therapy

Discussion Questions Posed

  • Grizzard inquired about proactive patient education and lipid-lowering interventions to help patients maintain lorlatinib therapy for long-term benefits

Castronovo asked about potentially useful tools for educating and monitoring patients on ALK inhibitors

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
EHA 2025 Congress Recap | Image Credit: Venngage
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo